Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$92,033
+$90,581 QoQ
Shares Held
4,919
+3269.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#200
of 256 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. RLAY ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
6,182,479 | $490,208,754 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
980,259 | $486,924,048 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
875,859 | $263,659,830 | |
| 4 | INCY |
Incyte Corp
|
1,132,050 | $128,329,182 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
174,515 | $108,817,078 | |
| 6 | MRNA |
Moderna, Inc.
|
944,457 | $66,140,319 | |
| 7 | INSM |
INSMED Inc
|
416,487 | $44,405,840 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
545,761 | $42,716,712 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,033 | 4,919 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,452 | 146 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,347 | 4,060 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,151,285 | 220,553 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,515,589 | 438,032 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $31,636 | 12,075 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $63,151 | 15,328 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $71,819 | 10,144 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $61,196 | 9,386 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $17,612 | 2,122 | Shares | Sole | 2024-11-05 | |
| 2023-12-31 | $306,043 | 27,797 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $127,478 | 15,158 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $118,315 | 9,420 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $79,352 | 4,818 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $215,881 | 14,450 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $28,789 | 1,287 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,219 | 431 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $128,669 | 4,299 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $943,655 | 30,728 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $603,799 | 19,150 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $151,957 | 4,153 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $130,155 | 3,765 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $14,254 | 343 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,235 | 29 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||